MARKET WIRE NEWS

AIMIA TO REPORT FOURTH QUARTER AND FULL YEAR 2025 RESULTS ON MARCH 24

MWN-AI** Summary

Aimia Inc. (TSX: AIM; JSE: AII), the Toronto-based diversified conglomerate, is set to announce its fourth quarter and full year financial results for 2025 on March 24, 2026. The announcement will detail the company’s performance for the period ending December 31, 2025, and is expected to be released at approximately 6:00 am ET.

Following the results release, Aimia will hold a live presentation via a webcast and teleconference call at 8:30 am ET on the same day. The event will allow stakeholders and interested parties to gain insights directly from management about the results and strategic direction of the company. Participants can join the presentation by dialing 1-888-699-1199 for North America or 416-945-7677 for international callers, and a webcast will also be available at the company’s investor relations page.

Listeners are encouraged to log in or dial in 15 minutes before the presentation starts to ensure they secure a connection for this informative session. The company will provide presentation materials on its website, ensuring that attendees have access to relevant data to enhance understanding.

Aimia aims to enhance shareholder value by reducing holding company costs and addressing the share price discount relative to the intrinsic value of its businesses. As a strategic priority, the effective utilization of loss carry-forwards is also central to their approach in creating value for shareholders. This upcoming report will be pivotal in revealing Aimia's progress in these areas as they navigate financial challenges and opportunities in the current market landscape. Further details and the archived presentation will be accessible from the Aimia website afterward.

MWN-AI** Analysis

As Aimia Inc. (TSX: AIM) prepares to report its fourth quarter and full year results for 2025 on March 24, 2026, investors should approach the upcoming results with a blend of optimism and caution. The company has been working strategically to enhance its value by reducing costs and increasing operational efficiency. Given the challenges faced by diversified conglomerates in today’s volatile market, the financial performance reported may reflect the effectiveness of these strategies.

Analysts and investors should closely monitor key performance indicators such as revenue growth, EBITDA margins, and cash flow generation. These metrics will indicate how well Aimia has been able to leverage its assets and optimize operational expenditures. Particularly of interest will be the company's updates on its efforts to manage holding company costs and its strategy for narrowing the discrepancy between its share price and the intrinsic value of its holdings.

The live conference call scheduled for 8:30 am ET on March 24 is an excellent opportunity for investors to gain insights from management regarding both financial results and future outlook. Participation in the call may provide a deeper understanding of how Aimia aims to utilize its loss carry-forwards strategically, which can play a significant role in driving long-term shareholder value.

Investors should also remain vigilant about market conditions around the announcement date. Financial results releases can often trigger volatility in stock prices, so it may be prudent to assess market sentiment and adjust positions accordingly.

In conclusion, while there may be potential for positive market reaction based on strategic advancements made by Aimia, prudence in evaluating the complete financial picture will serve investors best in navigating their investment decisions following the earnings announcement on March 24.

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.

Source: Canada Newswire

Canada NewsWire

TORONTO, March 5, 2026 /CNW/ - Aimia Inc. (TSX: AIM) (JSE: AII) will announce its fourth quarter and full year 2025 financial results for the period ended December 31, 2025 on Tuesday March 24, 2026.

Aimia's financial results are expected to be released at approximately 6:00 am ET followed by a live presentation by management via a webcast and teleconference call at 8:30 am ET the same day.

Aimia Q4 Earnings Conference Call/Webcast

  • Time: 8:30m ET
  • Date: March 24, 2026
  • The presentation will be available in a listen-only mode via:
  • Presentation materials to be referenced during the call will be available from the Company's website at https://www.aimia.com/investor-relations/events-presentations/
  • Listeners are encouraged to dial-in/log-in 15 minutes prior to start of the presentation to secure a line or test their connection.

An archive of Aimia's Q4 earnings presentation will be available from the Company's website.

About Aimia
Aimia Inc. (TSX: AIM; JSE:AII) is a diversified conglomerate focused on enhancing the value of its holdings. Headquartered in Toronto, Aimia's priorities include reducing its holding company costs, reducing the discount of its share price to the intrinsic value of its businesses, and efficiently utilizing its loss carry-forwards to create shareholder value.

For more information about Aimia, visit www.aimia.com

SOURCE Aimia Inc.

View original content: http://www.newswire.ca/en/releases/archive/March2026/05/c1155.html

FAQ**

What specific strategies does AIMIA Inc. plan to employ in 2026 to enhance shareholder value, especially in comparison to the performance of AIM ImmunoTech Inc. (AIM)?

In 2026, AIMIA Inc. plans to enhance shareholder value through strategic partnerships, innovation in loyalty programs, and targeted marketing, while closely monitoring AIM ImmunoTech Inc.'s performance to identify competitive advantages and market opportunities.

How will AIMIA's fourth quarter results reflect its efforts in reducing holding company costs, and what lessons can be drawn from AIM ImmunoTech Inc. (AIM) in this regard?

AIMIA's fourth quarter results will likely show improved profitability from reduced holding company costs, similar to AIM ImmunoTech Inc.'s emphasis on financial efficiency, highlighting the importance of cost management for long-term sustainability and investor confidence.

Can Aimia provide insight into how its financial outcomes for 2025 compare to those of AIM ImmunoTech Inc. (AIM), particularly in terms of market share and revenue growth?

As of October 2023, Aimia's financial projections for 2025 suggest a focus on strategic partnerships and loyalty programs, whereas AIM ImmunoTech Inc. primarily emphasizes biopharmaceutical innovation, making direct comparisons in market share and revenue growth challenging.

What key performance indicators will AIMIA focus on during the earnings call, and how do these compare to AIM ImmunoTech Inc. (AIM) metrics that investors should be aware of?

AIMIA will focus on key performance indicators such as revenue growth, patient enrollment metrics, and clinical trial milestones, which investors should compare to AIM ImmunoTech Inc.’s similar metrics for a comprehensive assessment of both companies' performance and potential.

**MWN-AI FAQ is based on asking OpenAI questions about AIM ImmunoTech Inc. (NYSE: AIM).

AIM ImmunoTech Inc.

NASDAQ: AIM

AIM Trading

-4.73% G/L:

$0.693 Last:

61,403 Volume:

$0.71 Open:

mwn-link-x Ad 300

AIM Latest News

AIM Stock Data

$3,240,384
3,276,294
0.11%
8
N/A
Biotechnology & Life Sciences
Healthcare
US
Ocala

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App